The Korean National Assembly Health and Welfare Committee member Rep. Jeon Jin-suk (Democratic Party) highlighted that recent legislative reforms targeting the management of medical narcotics prescriptions are yielding tangible results on the ground. In the 2024 national audit, she pointed out weaknesses in the existing system, noting that some patients were obtaining repeated narcotic prescriptions by visiting multiple healthcare facilities.
Following amendments to the relevant law, data show that the number of medical professionals who received information for violating narcotics misuse control criteria decreased in most drug categories in 2026 compared with 2025. Rep. Jeon attributed this decline to the strengthened regulatory framework introduced after the 2024 Food and Drug Safety Ministry audit.
The findings suggest that the new measures are effective in curbing the over‑prescription and potential abuse of controlled substances within the Korean healthcare system.
Regulatory UpdatesAug 31, 2026•1 min read
Korean Lawmaker Reports Decrease in Medical Narcotics Misuse Cases After Legislative Reform
Legislative changes aimed at improving narcotics prescription management have led to a measurable drop in reported misuse cases among medical professionals in 2026, according to Rep. Jeon Jin-suk.
Compiled by the PharmaCountry team · Source: KPA News
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating